Advanced synchronous rectal and prostate cancers diagnosed by lateral lymph node dissection: A case report

Lavan, 2016, The curative management of synchronous rectal and prostate cancer, Br. J. Radiol., 89, 10.1259/bjr.20150292 Sugihara, 2006, Indication and benefit of pelvic sidewall dissection for rectal cancer, Dis. Colon Rectum, 49, 1663, 10.1007/s10350-006-0714-z Kobayashi, 2009, Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection, Dis. Colon Rectum, 52, 567, 10.1007/DCR.0b013e3181a1d994 Saitoh, 1990, Two different lymph node metastatic patterns of a prostatic cancer, Cancer, 65, 1843, 10.1002/1097-0142(19900415)65:8<1843::AID-CNCR2820650830>3.0.CO;2-4 Smith, 1966, The lymphatics of the prostate, Investig. Urol., 3, 439 Agha, 2020, The SCARE 2020 guideline: updating consensus Surgical CAse REport (SCARE) guidelines, Int. J. Surg., 84, 226, 10.1016/j.ijsu.2020.10.034 Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394, 10.3322/caac.21492 Ishikawa, 2019, Laparoscopic abdominoperineal resection with lateral lymph node dissection for advanced rectal and prostate cancer with synchronous lateral lymph node metastases, Asian J. Endosc. Surg., 12, 118, 10.1111/ases.12598 Fujita, 2017, Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled,noninferiority trial, 266, 201 Schroder, 2014, Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up, Lancet, 384, 2027, 10.1016/S0140-6736(14)60525-0 Siegel, 2016, Cancer statistics, 2016, CA Cancer J. Clin., 66, 7, 10.3322/caac.21332 Kakehi, 2017, Committee for establishment of the evidenced-based clinical practice guideline for prostate cancer of the Japanese Urological A. Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition), Int. J. Urol., 24, 648, 10.1111/iju.13380 Hofman, 2020, Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study, Lancet, 395, 1208, 10.1016/S0140-6736(20)30314-7